FDA advisers consider weekly insult shot and more health headlines [Video]

Medical Watch Digest for May 27

FDA advisers consider weekly insult shot

Novo Nordisk is seeking approval for a drug called “Insulin Icodec.”

Phase 3 clinical trials found the once a week injection was better at reducing high blood glucose levels, compared to the once daily shot by the same drug maker.

But the weekly injection was associated with a higher incidence of hypoglycemia, which can lead to a loss of consciousness or seizures.

Seven out of 11 advisers voted no on Friday, when asked if they think the benefits of the weekly shot outweigh its risks.

The FDA does not have to accept their input when deciding whether to approve the drug.

Attention-deficit hyper-activity disorder is on the rise among children

A new report by the CDC finds one in nine children between the ages of 3 and 17 have been diagnosed with ADHD.

Researchers found that seven million kids received a diagnosis in 2022. That’s one million more than in 2016.

The increase comes as more girls are diagnosed …